Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes

British Journal of Pharmacology

Volumn 156, Issue 3, 2009, Pages 486-496

  Gallicchio, M ^a   Benetti, E ^a   Rosa, A C ^a   Fantozzi, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

MAPKs; Neuropeptides; NF B; Substance P; Tachykinins

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P46; NEUROKININ A; NEUROKININ A DERIVATIVE; NEUROKININ B; OSANETANT; PROSTAGLANDIN E2; SAREDUTANT; SENKTIDE; SUBSTANCE P; SUBSTANCE P DERIVATIVE; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; LIGAND;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIGAND BINDING; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME INDUCTION; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; HUMANS; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS; NF-KAPPA B; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTORS, TACHYKININ; SUBSTANCE P;

EID: 65449133959     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00033.x     Document Type: Article

References (50)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Azzolina A, Guarneri P, Lampisi N (2002). Involvement of p38 and JNK MAPKs pathways in substance P-induced production of TNF-alpha by peritoneal mast cells. Cytokine 18 : 72 80.
3. Baldwin AS Jr. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14 : 649 683.
4. 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br J Pharmacol 145 : 385 396.
5. Brunelleschi S, Vanni L, Ledda F, Giotti A, Maggi CA, Fantozzi R (1990). Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol 100 : 417 420.
6. Brunelleschi S, Tarli S, Giotti A, Fantozzi R (1991). Priming effects of mammalian tachykinins on human neutrophils. Life Sci 48 : PL1 5.
7. Brunelleschi S, Parenti A, Ceni E, Giotti A, Fantozzi R (1992). Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. Br J Pharmacol 107 : 964 969.
8. Brunelleschi S, Guidotto S, Viano I, Fantozzi R, Pozzi E, Ghio P et al. (1996). Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: a phenotypical and functional study. Neuropeptides 30 : 456 464.
9. Cedergren J, Follin P, Forslund T, Lindmark M, Sundqvist T, Skogh T (2003). Inducible nitric oxide synthase (NOS II) is constitutive in human neutrophils. APMIS 111 : 963 968.
10. Dianzani C, Lombardi G, Collino M, Ferrara C, Cassone MC, Fantozzi R (2001). Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils. J Leukoc Biol 69 : 1013 1018.
11. Dianzani C, Collino M, Lombardi G, Garbarino G, Fantozzi R (2003). Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br J Pharmacol 139 : 1103 1110.
12. Dirig DM, Yaksh TL (1999). In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin. Br J Pharmacol 126 : 1333 1340.
13. Gallicchio M, Rosa AC, Benetti E, Collino M, Dianzani C, Fantozzi R (2006). Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells. Br J Pharmacol 147 : 681 689.
14. Gerard NP, Eddy RL Jr., Shows TB, Gerard C (1990). The human neurokinin A (substance K) receptor. J Biol Chem 265 : 20455 20462.
15. Goode T, O'Connell J, Ho WZ, O'Sullivan GC, Collins JK, Douglas SD et al. (2000). Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells. Clin Diagn Lab Immunol 7 : 371 376.
16. Guo CJ, Lai JP, Luo HM, Douglas SD, Ho WZ (2002). Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes. J Neuroimmunol 131 : 160 167.
17. Holzer P (1988). Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24 : 739 768.
18. Improta G, Broccardo M (2006). Tachykinins: role in human gastrointestinal tract physiology and pathology. Curr Drug Targets 7 : 1021 1029.
19. Jeon HK, Jung NP, Choi IH, Oh YK, Shin HC, Gwag BJ (1999). Substance P augments nitric oxide production and gene expression in murine macrophages. Immunopharmacology 41 : 219 226.
20. Julius D, Basbaum AI (2001). Molecular mechanisms of nociception. Nature 413 : 203 210.
21. Kato T, Kitagawa S (2006). Regulation of neutrophil functions by proinflammatory cytokines. Int J Hematol 84 : 205 209.
22. Klassert TE, Pinto F, Hernández M, Candenas ML, Hernández MC, Abreu J et al. (2008). Differential expression of neurokinin B and hemokinin-1 in human immune cells. J Neuroimmunol 196 : 27 34.
23. Kojima T, Yamaguchi M, Kasai K (2006). Substance P stimulates release of RANKL via COX-2 expression in human dental pulp cells. Inflamm Res 55 : 78 84.
24. 2 expression through JAK-STAT activation in human colonic epithelial cells. J Immunol 176 : 5050 5059.
25. Kyriakis JM, Avruch J (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81 : 807 869.
26. Lai JP, Douglas SD, Ho WZ (1998). Human lymphocytes express substance P and its receptor. J Neuroimmunol 86 : 80 86.
27. Lecci A, Maggi CA (2001). Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept 101 : 1 18.
28. Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K (1997). The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol 159 : 4952 4958.
29. McLeish KR, Knall C, Ward RA, Gerwins P, Coxon PY, Klein JB et al. (1998). Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J Leukoc Biol 64 : 537 545.
30. Maggi CA (2000). Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul Pept 93 : 53 64.
31. Maggi CA, Schwartz TW (1997). The dual nature of the tachykinin NK1 receptor. Trends Pharmacol Sci 18 : 351 354.
32. Maloney CG, Kutchera WA, Albertine KH, McIntyre TM, Prescott SM, Zimmerman GA (1998). Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol 160 : 1402 1410.
33. Mapp CE, Miotto D, Braccioni F, Saetta M, Turato G, Maestrelli P et al. (2000). The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. Am J Respir Crit Care Med 161 : 207 215.
34. 1 receptors in human blood lymphocytes and granulocytes. Neuropsychobiology 50 : 221 225.
35. Marriott I, Mason MJ, Elhofy A, Bost KL (2000). Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol 102 : 163 171.
36. Nagano S, Otsuka T, Niiro H, Yamaoka K, Arinobu Y, Ogami E et al. (2002). Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils: involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines. Int Immunol 14 : 733 740.
37. 2. Adv Prostaglandin Thromboxane Res 6 : 129 137.
38. Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ (1984). Substance P recognition by a subset of human T lymphocytes. J Clin Invest 74 : 1532 1539.
39. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA (2004). Tachykinins and tachykinin receptors: a growing family. Life Sci 74 : 1445 1463.
40. Pinto FM, Almeida TA, Hernandez M, Devillier P, Advenier C, Candenas ML (2004). mRNA expression of tachykinins and tachykinin receptors in different human tissues. Eur J Pharmacol 494 : 233 239.
41. Regoli D, Boundon A, Fuchere J (1994). Receptors and antagonists for substance P and related peptides. Pharmacol Rev 46 : 551 599.
42. Richardson JD, Vasko MR (2002). Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302 : 839 845.
43. Takahashi K, Tanaka A, Hara M, Nakanishi S (1992). The primary structure and gene organization of human substance P and neuromedin K receptors. Eur J Biochem 204 : 1025 1033.
44. Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE (1991). Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem Biophys Res Commun 179 : 1232 1240.
45. Tokuda M, Miyamoto R, Sakuta T, Nagaoka S, Torii M (2005). Substance P activates p38 mitogen-activated protein kinase to promote IL-6 induction in human dental pulp fibroblasts. Connect Tissue Res 46 : 153 158.
46. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN (2006). Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38 : 1654 1661.
47. Tsuchida H, Takahashi S, Nosaka E, Mukaiyama O, Yamashita M, Morimoto K (2008). Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses. Eur J Pharmacol 586 : 306 312.
48. Vane JR, Bakhle YS, Botting RM (1998). Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38 : 97 120.
49. Yang CM, Hsiao LD, Chien CS, Lin CC, Luo SF, Wang CC (2002). Substance P-induced activation of mitogen-activated protein kinase associated with cell proliferation in human tracheal smooth muscle cells. Cell Signal 14 : 913 923.
50. 2) production by normal human polymorphonuclear neutrophils by enhancing cyclooxygenase 2 (COX-2) gene expression. Inflamm Res 47 : 167 173.